Prediction of Outcome by Echocardiography in Left Bundle Branch Block
EchoLBBB
Prediction of Heart-failure and Mortality by Echocardiographic Parameters and Machine Learning in Individuals With Left Bundle Branch Block
1 other identifier
observational
2,000
1 country
1
Brief Summary
Patients with left bundle branch block have an increased risk for the development of heart-failure and death. However, risk factors for unfavorable outcomes are still poorly defined. This study aims to identify echocardiographic parameters and ECG characteristics by machine learning in order to develop individual risk assessment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2020
CompletedFirst Posted
Study publicly available on registry
March 3, 2020
CompletedStudy Start
First participant enrolled
April 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2036
May 24, 2022
May 1, 2022
6.7 years
March 1, 2020
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiovascular death
Timepoint (day) of death and its cause
15 years
Death of any cause
Timepoint (day) of death and its cause
15 years
Secondary Outcomes (1)
Hospital admission due to heart-failure
15 years
Other Outcomes (3)
Remodelling
5 years
Cardiac function
5 years
Heart failure
5 years
Eligibility Criteria
Patients will be recruited based on epidemiological studies from Tromsø, where LBBB or ventricular pacing has been identified. Further in-hospital patients and patients from the out-patient clinics will be recruited due to ECG assessment
You may qualify if:
- QRS complex \>130 ms and R-wave duration in
- V6 \>70 ms
- ventricular pacing\>50%
- Previously implanted cardiac resynchronisation therapy (CRT)
You may not qualify if:
- Typical right bundle branch block.
- No ability to give informed consent,
- non-cardiovascular co-mobidities with reduced life-expectancy \< 1 year
- patients with complex congenital heart disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital of North Norwaylead
- Oslo University Hospitalcollaborator
- University of Bergencollaborator
- Norwegian University of Science and Technologycollaborator
- University of Tromsocollaborator
- KU Leuvencollaborator
Study Sites (1)
University Hospital North Norway
Tromsø, Troms, 9038, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Assami Rösner, MD,PhD
University Hospital North Norway
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
March 1, 2020
First Posted
March 3, 2020
Study Start
April 15, 2021
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2036
Last Updated
May 24, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
- Time Frame
- 15 years
- Access Criteria
- Patient have been included and five-year outcome data will have been revised.
All individual analytic codes for participants fom other Norwegian Hospitals need to be transferred to University Hospital North Norway (UNN) for registering outcome follow-up